Skip to main content

Table 3 Mean score values for the global QOL and the different functional scales of the EORTC QLQ-C30

From: Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma

EORTCQLQ-C30 Scales

T0

T1

T2

T3

Friedman Test

p (T0:T1)

p (T1:T2)

p (T2:T3)

p (T0:T3)

Global QOL

68.22 ± 8.96

63.54 ± 20.2

66.04 ± 20.04

68.75 ± 18.09

0.001

0.001

0.130

0.41

0.431

Functional scales

Physical functioning

93.01 ± 14.61

89.37 ± 17.28

89.24 ± 16.52

86.38 ± 19.04

< 0.001

< 0.001

0.796

0.005

< 0.001

Role functioning

83.62 ± 25.33

68.85 ± 31.57

73.75 ± 28.39

72.48 ± 25.41

< 0.001

< 0.001

0.018

0.113

< 0.001

Cognitive functioning

87.43 ± 17.42

81.27 ± 19.01

83.89 ± 21.14

81.45 ± 21.12

< 0.001

< 0.001

0.014

0.069

0.004

Emotional functioning

64.27 ± 26.01

65.35 ± 25.76

68.49 ± 23.32

73.30 ± 21.92

0.088

    

Social functioning

81.36 ± 24.57

74.68 ± 26.20

79.55 ± 23.71

83.01 ± 22.51

0.006

    
  1. QOL: quality of life; EORTC QLQ-C30: European Organization for Research and Treatment of Cancer QOL questionnaire; T0: before clip-surgery; T1: between clip-surgery and proton therapy; T2: after proton therapy; and T3: three months after treatment. Values are the mean scores ± standard deviation. Bold font: In cases where the Friedman pre-test showed significance, changes between two assessment points are considered significant for p-values ≤ 0.003